会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • VASOCONSTRICTOR FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING AND APPARATUS FOR DELIVERY THEREOF
    • 用于治疗异常子宫切除术的血管造影剂及其输送装置
    • WO2013109365A1
    • 2013-07-25
    • PCT/US2012/069257
    • 2012-12-12
    • GOEDEKE, Steven D.EUTENEUER, Charles L.HEKTNER, Thomas K.CROMPTON, David M.
    • GOEDEKE, Steven D.EUTENEUER, Charles L.HEKTNER, Thomas K.CROMPTON, David M.
    • A61K31/4174A61P7/04A61M25/00
    • A61K31/4174A61F6/225A61F13/2074A61K9/0036A61M31/002
    • Method and apparatus (100, 161, 200, 215, 300, 400, 450, 500, 600, 650) are disclosed for applying a therapeutic amount of a non-systemic vasoconstrictor inside the uterus (12) to control abnormal uterine bleeding. The abnormal bleeding can be due to excessive menstrual blood flow, bleeding from a surgical procedure, postpartum bleeding or any other acute or chronic condition. The vasoconstrictor includes topical agents such as an alpha-adrenergic agonist, for example oxymetazoline. The delivery system (100, 200) can include a catheter having means for retaining position of a distal portion (102) within the uterus (12). A proximal portion (104) can extend outside of the body for coupling to a vasoconstrictor source, or alternatively, the proximal portion (104) can terminate within the vaginal canal (20) and include a docking port (154) for coupling to a source of vasoconstrictor that is inserted therein. In other embodiments, an applicator (161, 215, 300, 400, 450, 500, 600, 650) is disclosed that is positioned in fluid communication with the lumen of the cervix (24) and allows application of a vasoconstrictor therein.
    • 公开了用于在子宫(12)内施用治疗量的非系统性血管收缩剂以控制异常子宫出血的方法和装置(100,161,200,215,300,400,450,500,600,650)。 异常出血可能是由于月经量过多,外科手术出血,产后出血或其他急性或慢性疾病。 血管收缩剂包括局部剂,例如α-肾上腺素能激动剂,例如羟甲唑啉。 输送系统(100,200)可以包括具有用于保持在子宫(12)内的远端部分(102)的位置的装置的导管。 近端部分(104)可以延伸到身体的外部,用于联接到血管收缩源,或者替代地,近端部分(104)可以终止在阴道内(20)内,并且包括用于联接到源的对接端口(154) 的血管收缩剂。 在其它实施例中,公开了一种定位成与子宫颈(24)的内腔流体连通并且允许在其中施加血管收缩剂的施加器(161,215,300,400,450,500,600,650)。
    • 5. 发明申请
    • VASOCONSTRICTOR FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING
    • 用于治疗异常子宫切除术的血管造影剂
    • WO2013090321A1
    • 2013-06-20
    • PCT/US2012/069075
    • 2012-12-12
    • GOEDEKE, Steven D.
    • GOEDEKE, Steven D.
    • A61K31/4174A61K45/06A61K9/02A61F13/20A61P7/04
    • A61K31/4174A61F6/225A61F13/2074A61K9/0036A61M31/002
    • Method and apparatus (10, 50) are disclosed for applying a therapeutic amount of a vasoconstrictor (20, 54) within the vaginal canal to control abnormal uterine bleeding. The abnormal bleeding can be due to excessive menstrual blood flow, bleeding from a surgical procedure, postpartum bleeding or any other acute or chronic condition. The vasoconstrictor (20, 54) includes topical agents such as an alpha-adrenergic agonist, for example oxymetazoline. The vasoconstrictor (20, 54) can be applied within the vaginal canal using any of many delivery apparatus. The vasoconstrictor (20, 54) can be included on a carrier member (10, 50) that is positioned in the vaginal canal and remains in place for a period of time, such as a tampon (12). In some embodiments, the carrier member (10, 50) can be a polymer ring (52) or other shape that is inserted in the upper portion of the vaginal canal, such as the fornix area.
    • 公开了用于在阴道内施用治疗量的血管收缩剂(20,54)以控制异常子宫出血的方法和装置(10,50)。 异常出血可能是由于月经量过多,外科手术出血,产后出血或其他急性或慢性疾病。 血管收缩剂(20,54)包括局部剂,例如α-肾上腺素能激动剂,例如羟甲唑啉。 血管收缩剂(20,54)可以使用任何多种递送装置在阴道内施用。 血管收缩剂(20,54)可以包含在位于阴道内的载体构件(10,50)上并保持一段时间的位置,例如卫生棉条(12)。 在一些实施例中,载体构件(10,50)可以是聚合物环(52)或插入阴道的上部,例如穹窿区域的其他形状。